UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013030
Receipt number R000014476
Scientific Title Study of metabolism-related markers of bariatric surgery before and after in obese patients with type 2 diabetes
Date of disclosure of the study information 2014/01/31
Last modified on 2015/09/26 01:56:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of metabolism-related markers of bariatric surgery before and after in obese patients with type 2 diabetes

Acronym

Study of metabolism-related markers of bariatric surgery before and after in obese patients with type 2 diabetes

Scientific Title

Study of metabolism-related markers of bariatric surgery before and after in obese patients with type 2 diabetes

Scientific Title:Acronym

Study of metabolism-related markers of bariatric surgery before and after in obese patients with type 2 diabetes

Region

Japan


Condition

Condition

obese patients with type 2 diabetes

Classification by specialty

Medicine in general Surgery in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

assessment of blood glucose control , insulin sensitivity and secretion

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1)HbA1c
2)body weight
3)matsuda index
4)insulinogenic index

Key secondary outcomes

1)AST,ALT
2)T-chol,TG,HDL-chol,LDL-chol
3)active-ghrelin,desacyl-ghrelin,leptin,adiponectin
4)urinalysis


Base

Study type


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

1)standard therapy(diet,exercise,and oral hypoglycemic agent)

Interventions/Control_2

2)bariatric surgery

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

obese patients body mass index over 32 with type 2 diabetes

Key exclusion criteria

1.Individuals recieved insulin therapy
2.Individuals recieved steroid therapy ,immunosuppressant , Azole antifungal agents.
3.Individuals judged to have nephrotic syndrome.
4.cerebral vascular disorder and acute coronary artery disease within 6 months
5.Individuals judged to have severe heart failure , severe irregular Heart Beat.Individuals judged to have myocardial ischemia and recieve PCI.
6.Pregnant women, or women with intending
to become pregnant, and lactating women.
7.Individuals judged by the doctor to be
unsuitable.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshiaki Hanafusa

Organization

Osaka Medical College

Division name

Department of Internal Medicine (1)

Zip code


Address

2-7 Daigaku-machi, Takatsuki City, Osaka

TEL

072-683-1221

Email

hanafusa@poh.osaka-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hisashi Imbe

Organization

Osaka Medical College

Division name

Department of Internal Medicine (1)

Zip code


Address

2-7 Daigaku-machi, Takatsuki City, Osaka

TEL

072-683-1221

Homepage URL


Email

in1297@poh.osaka-med.ac.jp


Sponsor or person

Institute

Department of Internal Medicine(1),Osaka
Medical College

Institute

Department

Personal name



Funding Source

Organization

Department of Internal Medicine(1),Osaka
Medical College

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 01 Month 31 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Impaired glucose tolerance was improved.

The 34th Annual Meeting of Japan Society for the Study of Obesity.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 06 Month 07 Day

Date of IRB


Anticipated trial start date

2012 Year 06 Month 07 Day

Last follow-up date

2015 Year 09 Month 03 Day

Date of closure to data entry

2015 Year 09 Month 03 Day

Date trial data considered complete

2015 Year 09 Month 03 Day

Date analysis concluded

2015 Year 09 Month 03 Day


Other

Other related information



Management information

Registered date

2014 Year 01 Month 31 Day

Last modified on

2015 Year 09 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014476


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name